Immunosuppression: Clinical Trials

2 trials for Immunosuppression, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 terminated. 2 Not applicable.

By phase and status

PhaseTrialsStatus
Not applicable2Terminated 2

Follow Immunosuppression: new trials by email Literature Review of Immunosuppression trials Research Report on Immunosuppression

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
ImmunoCARE: Rapid, Accurate COVID Testing to Reduce Hospitalization of Immunocompromised Individuals
Access to Cue Health COVID-19 Remote testing and treatment for COVID-19 - Immunodeficiency, Immunosuppression
Not applicableTerminatedScripps Translational Science Institute21172022-12-222025-08-08
Evaluate Tolerability of Myfortic®/Simulect® and Tacrolimus Without Steroids in Three Patient Populations
Gastric emptying test - Diabetes, Immunosuppression
Not applicableTerminatedThe University of Texas Medical Branch, Galveston22011-03-012020-11-17

Narrower conditions

COVID-19 (1)  ·  Diabetes Mellitus (1)  ·  Graft vs Host Disease (1)  ·  HIV Infections (1)  ·  Immunologic Deficiency Syndromes (1)  ·  Leukemia (1)  ·  Lymphoma (1)  ·  Multiple Myeloma (1)  ·  Neoplasms (1)

Broader conditions

Blood Protein Disorders (1)  ·  Blood-Borne Infections (1)  ·  Cardiovascular Diseases (1)  ·  Communicable Diseases (1)  ·  Coronaviridae Infections (1)  ·  Coronavirus Infections (1)  ·  Endocrine System Diseases (1)  ·  Genital Diseases (1)  ·  Glucose Metabolism Disorders (1)  ·  Hematologic Diseases (1)  ·  Hemic and Lymphatic Diseases (1)  ·  Hemorrhagic Disorders (1)  ·  Hemostatic Disorders (1)  ·  Immune System Diseases (1)  ·  Immunoproliferative Disorders (1)

Interventions

Therapeutics (1)

Sponsors

Scripps Translational Science Institute (1)  ·  The University of Texas Medical Branch, Galveston (1)

Countries

United States (2)

Top investigators

Luca Cicalese, MD (1)

Results publications

PMID 40503088